CTD Holdings, Inc. (OTCMKTS:CTDH) Director William S. Shanahan acquired 200,000 shares of CTD stock in a transaction that occurred on Tuesday, September 10th. The stock was acquired at an average cost of $0.19 per share, for a total transaction of $38,000.00.
CTDH stock opened at $0.19 on Friday. The company’s fifty day simple moving average is $0.22 and its 200 day simple moving average is $0.48. CTD Holdings, Inc. has a 12-month low of $0.16 and a 12-month high of $1.18. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.59 and a current ratio of 2.74.
CTD Company Profile
CTD Holdings, Inc, a biotechnology company, develops cyclodextrin-based products for the treatment of diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. The company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.
Featured Story: Gap Up Stocks
Receive News & Ratings for CTD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CTD and related companies with MarketBeat.com's FREE daily email newsletter.